NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · page 18 of 25
The slide uses preclinical data to demonstrate efficacy superiority over a market-leading GLP-1 agonist.
Pitch deck · competitive_analysis · compare_peers · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
chart 3/3 disclaimer 1/1 paragraph 1/1 title 2/2
Components 7
bar-vertical line line disclaimer paragraph action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1